AbbVie (ABBV) EBT (2012 - 2026)

AbbVie (ABBV) has reported EBT for 15 consecutive years, with $4.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT rose 175.29% year-over-year to $4.3 billion in Q2 2026; TTM through Jun 2026 was $8.7 billion, a 187.1% increase from a year earlier, with the FY2025 full-year figure at $6.6 billion, up 77.53% from the prior year.
• EBT was $4.3 billion for Q2 2026 at AbbVie, up from $1.0 billion in the prior quarter.
• Over five years, EBT peaked at $4.9 billion in Q1 2022 and troughed at -$2.3 billion in Q4 2024.
• A 5-year average of $2.0 billion and a median of $1.9 billion in 2023 frame the typical range for EBT.
• The widest YoY moves for EBT: up 269.47% in 2024, down 287.21% in 2024.
• Over 5 years, EBT stood at $3.0 billion in 2022, then plunged by 59.12% to $1.2 billion in 2023, then sank by 287.21% to -$2.3 billion in 2024, then surged by 217.58% to $2.7 billion in 2025, then surged by 60.34% to $4.3 billion in 2026.
• The last three EBT figures came in at $4.3 billion (Q2 2026), $1.0 billion (Q1 2026), and $2.7 billion (Q4 2025), per Business Quant data.